SWOG S1900A

Primary Category:

Treatment Protocols

Disease Category:

Lung, Lung - Non-Small Cell, Lung - Non-Small Cell Metastatic

Status:

Closed

A Phase II Study of Rucaparib in Patients with Genomic LOH High and/or Deleterious BRCA1/2 Mutation Stage IV or Recurrent Non-Small Cell Lung Cancer (LUNG-MAP Sub-Study)

NCT#03845296

See Screening Protocol LUNGMAP

S1900A is permanently closed to new accrual effective, February 1, 2021.

Cohort 2 (patients with non-squamous cell lung cancer) is permanently closed to accrual effective February 1. 2021.

Cohort 1 (patients with squamous cell lung cancer) permanently closed to accrual effective November 15, 2020.